Covid Vaccine Shortage In India To Continue Till July, Says Adar Poonawalla

New Delhi: Amid the shortage of vaccines against Covid-19 in India, Chief Executive Officer ( CEO ) of Serum Institute of India (SII) Adar Poonawalla has said that the issue shall continue till the month of July.

The capacity shall be increased to 100 million doses by July from 60-70 million a month which is the current production in India, added the ceo of SII.

According to reports, due to lack of orders to the SII for Covid vaccines the company had not increased the number of production earlier.

On Saturday the CEO tweeted and said about the production of Covishield that it has been started in full swing at SII’s facility in Pune. “Pleased to state that COVISHIELD’s production is in full swing in Pune. I look forward to reviewing operations upon my return in a few days,” said the tweet.

Had an excellent meeting with all our partners & stakeholders in the U.K. Meanwhile, pleased to state that COVISHIELD’s production is in full swing in Pune. I look forward to reviewing operations upon my return in a few days.

— Adar Poonawalla (@adarpoonawalla) May 1, 2021

Meanwhile, the Serum Institute of India is planning to initiate vaccine production in other countries as it struggles to meet supply commitments.

So far, India has given at least first dose of Covid vaccine to 15.7 crore people while more than 2 per cent of the population has received both the doses.